These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26263910)

  • 21.
    Solomon VR; Alizadeh E; Bernhard W; Hartimath SV; Hill W; Chekol R; Barreto KM; Geyer CR; Fonge H
    Mol Pharm; 2019 Dec; 16(12):4807-4816. PubMed ID: 31518138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
    Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
    J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.
    Brierley GV; Macaulay SL; Forbes BE; Wallace JC; Cosgrove LJ; Macaulay VM
    Endocrinology; 2010 Apr; 151(4):1418-27. PubMed ID: 20179263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts.
    Goetsch L; Gonzalez A; Leger O; Beck A; Pauwels PJ; Haeuw JF; Corvaia N
    Int J Cancer; 2005 Jan; 113(2):316-28. PubMed ID: 15386423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and preclinical evaluation of cixutumumab drug conjugates in a model of insulin growth factor receptor I (IGF-1R) positive cancer.
    Solomon VR; Alizadeh E; Bernhard W; Makhlouf A; Hartimath SV; Hill W; El-Sayed A; Barreto K; Geyer CR; Fonge H
    Sci Rep; 2020 Oct; 10(1):18549. PubMed ID: 33122707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling.
    Garofalo C; Manara MC; Nicoletti G; Marino MT; Lollini PL; Astolfi A; Pandini G; López-Guerrero JA; Schaefer KL; Belfiore A; Picci P; Scotlandi K
    Oncogene; 2011 Jun; 30(24):2730-40. PubMed ID: 21278796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of insulin-like growth factor receptor signaling mediates resistance to histone deacetylase inhibitors.
    Kim JS; Lee SC; Min HY; Park KH; Hyun SY; Kwon SJ; Choi SP; Kim WY; Lee HJ; Lee HY
    Cancer Lett; 2015 Jun; 361(2):197-206. PubMed ID: 25721083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety, tolerability, and pharmacokinetics of single and multiple doses of intravenous cixutumumab (IMC-A12), an inhibitor of the insulin-like growth factor-I receptor, administered weekly or every 2 weeks in patients with advanced solid tumors.
    Higano CS; Berlin J; Gordon M; LoRusso P; Tang S; Dontabhaktuni A; Schwartz JD; Cosaert J; Mehnert JM
    Invest New Drugs; 2015 Apr; 33(2):450-62. PubMed ID: 25749986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
    Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
    Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implication of insulin receptor A isoform and IRA/IGF-IR hybrid receptors in the aortic vascular smooth muscle cell proliferation: role of TNF-α and IGF-II.
    Gómez-Hernández A; Escribano Ó; Perdomo L; Otero YF; García-Gómez G; Fernández S; Beneit N; Benito M
    Endocrinology; 2013 Jul; 154(7):2352-64. PubMed ID: 23677929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma.
    Garofalo C; Mancarella C; Grilli A; Manara MC; Astolfi A; Marino MT; Conte A; Sigismund S; Carè A; Belfiore A; Picci P; Scotlandi K
    Mol Endocrinol; 2012 Sep; 26(9):1603-16. PubMed ID: 22798295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells.
    Nahta R; Yuan LX; Zhang B; Kobayashi R; Esteva FJ
    Cancer Res; 2005 Dec; 65(23):11118-28. PubMed ID: 16322262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinase.
    Sabbatini P; Rowand JL; Groy A; Korenchuk S; Liu Q; Atkins C; Dumble M; Yang J; Anderson K; Wilson BJ; Emmitte KA; Rabindran SK; Kumar R
    Clin Cancer Res; 2009 May; 15(9):3058-67. PubMed ID: 19383820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.
    Vella V; Malaguarnera R; Nicolosi ML; Palladino C; Spoleti C; Massimino M; Vigneri P; Purrello M; Ragusa M; Morrione A; Belfiore A
    Oncotarget; 2017 Jun; 8(26):43248-43270. PubMed ID: 28591735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer.
    Buck E; Mulvihill M
    Expert Opin Investig Drugs; 2011 May; 20(5):605-21. PubMed ID: 21446886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain.
    Hexnerová R; Křížková K; Fábry M; Sieglová I; Kedrová K; Collinsová M; Ullrichová P; Srb P; Williams C; Crump MP; Tošner Z; Jiráček J; Veverka V; Žáková L
    J Biol Chem; 2016 Sep; 291(40):21234-21245. PubMed ID: 27510031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delineation of the IGF-II C domain elements involved in binding and activation of the IR-A, IR-B and IGF-IR.
    Henderson ST; Brierley GV; Surinya KH; Priebe IK; Catcheside DE; Wallace JC; Forbes BE; Cosgrove LJ
    Growth Horm IGF Res; 2015 Feb; 25(1):20-7. PubMed ID: 25458127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling.
    Varewijck AJ; Brugts MP; Frystyk J; Goudzwaard JA; Uitterlinden P; Waaijers AM; Feng Y; Dimitrov DS; Lamberts SW; Hofland LJ; Janssen JA
    Mol Cell Endocrinol; 2013 Jan; 365(1):17-24. PubMed ID: 22982059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered expression of insulin receptor isoforms in breast cancer.
    Huang J; Morehouse C; Streicher K; Higgs BW; Gao J; Czapiga M; Boutrin A; Zhu W; Brohawn P; Chang Y; Viner J; LaVallee T; Richman L; Jallal B; Yao Y
    PLoS One; 2011; 6(10):e26177. PubMed ID: 22046260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid.
    Malaguarnera R; Frasca F; Garozzo A; Gianì F; Pandini G; Vella V; Vigneri R; Belfiore A
    J Clin Endocrinol Metab; 2011 Mar; 96(3):766-74. PubMed ID: 21123448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.